Guzman Acain is Philippine Intellectual Property Law Firm. The Firm advises clients in securing patents, trademarks and copyrights and instituting programs to prevent the loss of trade secrets, assist in exploiting intellectual property rights through licensing, joint venture and technology transfer agreements. We also enforce our clients’ patent, trademark and copyright rights and investigate and defend them against infringement assertions by others.
In addition to counseling clients on the identification, maintenance, and protection of their trade secrets and other confidential information, we also counsel clients concerning the validity and valuation of intellectual property when faced with potential acquisition, threat of infringement claims or infringement by others.
Intellectual Property Litigation
We handle all aspects of intellectual property litigation, including infringement cases before the Courts in the Philippines, ownership disputes, and contested proceedings before the Intellectual Property Office. Our primary goal is to successfully resolve infringement matters through Alternative
Dispute Resolution when appropriate before costly litigation becomes necessary.
Trademark Licensing and Assignments
Our service in this area ranges from full-scale franchising strategies to individual trademark licenses and assignments.
Intellectual Property Ownership and Registration
We also provide full copyright and trademark registration services and, in appropriate cases, train clients to handle routine applications in-house, with advice from us only as needed. We also file for and o behalf of our clients the application for registration of Copyrights and Trademarks.
Represented various companies in the US, Europe, Australia, Asia, the Middle East, and the ASEAN Region apply for their Trademarks, and Patents under the Patent Cooperation Treaty at the Philippine Intellectual Property Office.
Successfully defended and obtained a favorable judgment for a local Pharmaceutical client against Pfizer regarding patent infringement.
RELATED NEWS AND INSIGHTS
Sel-J Pharmaceuticals’ Ampicillin Sulbactam (with brand name Unasan) wins the patent case filed against them by Pfizer, owner of the leading innovator brand Unasyn. The case, initially filed by Pfizer in October 2008, alleges that Unasan infringes their patent for Unasyn.Read more